Sermorelin tablets vs nasal spray: compare absorption, dosing, cost, and research limits so you can judge which delivery method fits your goals.
Neither sermorelin tablets nor sermorelin nasal spray is supported by strong human data, and neither form is FDA-approved for human use. In the United States, sermorelin has only ever been approved as a subcutaneous injection, so tablets and nasal sprays sold online are unapproved products with unverified potency. If reliable absorption matters, injection remains the best-studied delivery route.
Sermorelin Tablets vs Nasal Spray at a Glance
The two routes fail in different ways: tablets run into digestion, while nasal sprays run into limited and uneven absorption.
| Factor | Sermorelin tablets | Sermorelin nasal spray | Subcutaneous injection |
|---|---|---|---|
| Absorption route | Swallowed; passes through stomach and liver | Absorbed through the nasal lining | Injected into fatty tissue |
| Bioavailability | Very low; most peptide is broken down before absorption | Low; typically a small fraction of the labeled dose | High; the only route with human pharmacokinetic data |
| Dose consistency | Poor | Variable between sprays, brands, and users | Good with a calibrated syringe |
| FDA status | Not approved | Not approved | Previously approved (Geref), now discontinued; compounded by prescription |
| Human evidence | Essentially none | Very limited | Clinical trials in growth hormone deficiency |
Why Sermorelin Is Usually Given as an Injection
Sermorelin is a 44-amino-acid peptide that mimics growth hormone-releasing hormone (GHRH). Because it is a peptide, it is fragile: stomach acid and digestive enzymes break it into fragments, and the nasal lining lets only a small fraction of a dose cross into the bloodstream intact.
Injectable sermorelin was studied in children with growth hormone deficiency before the brand product was withdrawn from the market in 2008. That injectable form is the only version with real pharmacokinetic data behind it.
That does not make tablets or sprays automatically unsafe. It means nobody has measured how much sermorelin actually reaches the blood from either one.
Sermorelin Tablets: Where Oral Delivery Falls Short
Tablets are the hardest route for a peptide of this size. The main obstacles are predictable:
- Proteases in the stomach and small intestine degrade peptides before absorption can occur.
- Any peptide that survives digestion passes through the liver, where it is broken down further.
- Most tablets sold as sermorelin do not publish independent lab testing of content or purity.
No published human study shows that sermorelin taken orally raises IGF-1 levels in a predictable way. Some products labeled as sermorelin tablets are actually amino acid blends or underdosed capsules, which makes user reports hard to interpret.
Sermorelin Nasal Spray: Bioavailability and Product Consistency
Sermorelin nasal spray bioavailability is generally considered low. Peptide drugs delivered intranasally typically absorb at a rate in the low single digits, which means the amount reaching circulation is a small and inconsistent share of what the label claims.
When people compare sermorelin nasal spray vs injection, the difference comes down to two things: how much peptide reaches the blood, and how consistently it does so. An injection delivers a known amount. A nasal spray delivers a variable amount that depends on technique, mucus, congestion, and the formulation itself.
Other practical issues show up repeatedly:
- There is no standardized formulation, so concentration per spray varies by vendor.
- Sterility, preservatives, and pH are rarely verified by third-party testing.
- Storage and shelf-life instructions are often vague or inconsistent.
Cost, Dosing, and Day-to-Day Use
Prices change constantly, so treat any listing you see online as a snapshot rather than a benchmark.
| Route | Typical advertised schedule | Monitoring typically recommended |
|---|---|---|
| Tablets | Daily, sometimes split into two doses | IGF-1 and symptom review with a clinician |
| Nasal spray | Daily, one or more sprays per nostril | IGF-1, plus review of nasal irritation |
| Injection | Daily subcutaneous dose, often at bedtime | IGF-1, thyroid and glucose markers under medical supervision |
Nasal sprays are usually the most convenient option and tablets the easiest to store, but convenience does not change how much of the peptide actually gets absorbed.
Safety and Legal Status
Sermorelin is a prescription peptide in the United States, and it is not approved for over-the-counter sale in any form. Nasal sprays and tablets marketed online usually carry "for research use only" labels, which means the seller is not claiming the product is safe or legal for human consumption.
Commonly reported side effects of GHRH-type peptides include injection site reactions, flushing, headache, and dizziness. Because sermorelin increases growth hormone signaling, it can also raise IGF-1, and persistently elevated IGF-1 is a real concern that requires bloodwork and medical oversight.
Anyone considering sermorelin in any form should speak with a licensed healthcare professional first, especially people with a history of cancer, pituitary disease, or diabetes.
How Sermorelin Compares With Other Research Peptides
Sermorelin vs aod 9604 comes up often, but the two are not interchangeable: AOD 9604 is a fragment of human growth hormone studied for fat metabolism, while sermorelin acts upstream by stimulating natural growth hormone release.
Other peptides raise the same delivery questions. PT-141 nasal spray (bremelanotide) has been studied intranasally, but the FDA-approved version is a subcutaneous injection sold as Vyleesi, which is why pt-141 nasal spray vs injection comparisons usually end with the same conclusion about absorption.
If you read a dsip nasal spray review, keep in mind that almost all of that content is anecdotal. There are no controlled human trials supporting the claims vendors make about DSIP delivered through the nose.
Bottom Line
Between the two, nasal spray has a slightly better theoretical case than tablets, because at least some intact peptide can cross the nasal lining. Neither matches injection for absorption or dose consistency, and neither has human data comparable to the injectable form.
Sermorelin tablets and nasal sprays are unapproved products with unverified dosing, and any decision about using them belongs with a physician who can monitor IGF-1 and overall health.
Frequently Asked Questions
Is sermorelin nasal spray as effective as injections?
No. Injectable sermorelin is the only form with published human pharmacokinetic and clinical data, and intranasal peptides typically absorb at only a small fraction of an injected dose. Nasal sprays also vary in concentration and spray volume, so the delivered dose is inconsistent from product to product.
Do sermorelin tablets actually work?
There is no published human evidence that oral sermorelin reliably raises IGF-1. Sermorelin is a 44-amino-acid peptide, and peptides of that size are largely destroyed by stomach acid and digestive enzymes before they can be absorbed. Products sold as sermorelin tablets often lack independent lab testing.
Is sermorelin nasal spray legal to buy in the United States?
Sermorelin is a prescription peptide and is not approved for over-the-counter sale in any form. Nasal sprays sold online are usually labeled "for research use only," which means the seller does not claim the product is intended for human use, and purity and sterility are generally unverified.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.